{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:44:17Z","timestamp":1791081857057,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/mbc.0b013e32832da1c5","type":"journal-article","created":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T03:14:48Z","timestamp":1254194088000},"page":"535-540","source":"Crossref","is-referenced-by-count":74,"title":["Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P)"],"prefix":"10.1097","volume":"20","author":[{"given":"Gerhard","family":"Dickneite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Pragst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Joch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett E","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210203","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1423-0410.2007.01024.x","article-title":"Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding","volume":"94","author":"Dan\u00e9s","year":"2008","journal-title":"Vox Sang"},{"key":"R2-8-20210203","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/bja\/aen270","article-title":"Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations","volume":"101","author":"Fenger-Eriksen","year":"2008","journal-title":"Br J Anaesth"},{"key":"R3-8-20210203","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1213\/ane.0b013e318163fb26","article-title":"Fibrinogen in craniosynostosis surgery","volume":"106","author":"Haas","year":"2008","journal-title":"Anesth Analg"},{"key":"R4-8-20210203","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-3148.2008.00854.x","article-title":"Fibrinogen concentrate for acquired hypofibrinogenaemic states","volume":"18","author":"Weinkove","year":"2008","journal-title":"Transfus Med"},{"key":"R5-8-20210203","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2516.2006.01299.x","article-title":"Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review","volume":"12","author":"Girolami","year":"2006","journal-title":"Haemophilia"},{"key":"R6-8-20210203","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1152\/jappl.1959.14.6.943","article-title":"Biologic assay of a thrombosis-inducing activity in human serum","volume":"14","author":"Wessler","year":"1959","journal-title":"J Appl Physiol"},{"key":"R7-8-20210203","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0049-3848(92)90142-W","article-title":"Recombinant human factor VIIa (rFVIIa) in a rabbit stasis model","volume":"67","author":"Diness","year":"1992","journal-title":"Thromb Res"},{"key":"R8-8-20210203","first-page":"194","article-title":"Therapy of fibrinogen deficiency states: results of an observational study","volume":"16","author":"Bonik","year":"1996","journal-title":"H\u00e4mostaseologie"},{"key":"R9-8-20210203","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2004.08.003","article-title":"Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency","volume":"32","author":"Kreuz","year":"2005","journal-title":"Transfus Apher Sci"},{"key":"R10-8-20210203","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1055\/s-0037-1614201","article-title":"Lepirudin therapy for thrombotic complications in congenital afibrinogenaemia","volume":"91","author":"Schuepbach","year":"2004","journal-title":"Thromb Haemost"},{"key":"R11-8-20210203","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1213\/01.ANE.0000173666.80578.49","article-title":"Use of recombinant factor VIIa (Novoseven\u00ae) in combination with other coagulation products led to a thrombotic occlusion of the truncus brachiocephalicus in a neonate supported by extracorporal membrane oxygenation","volume":"101","author":"Velik-Salchner","year":"2005","journal-title":"Anesth Analg"},{"key":"R12-8-20210203","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/ajh.20923","article-title":"Aprotinin-associated hemolytic thrombotic microangiopathy in a patient with acute myelogenous leukemia (AML) and systemic coagulopathy","volume":"82","author":"Langer","year":"2007","journal-title":"Am J Hematol"},{"key":"R13-8-20210203","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.surneu.2007.10.034","article-title":"Spontaneous extra-axial intracranial hemorrhage followed by thrombosis in congenital afibrinogenemia: perioperative management of this rare combination.","volume":"71","author":"Pati","year":"2009","journal-title":"Surg Neurol"},{"issue":"Suppl 1","key":"R14-8-20210203","first-page":"0270","article-title":"Prophylactic treatment of afibrinogenemia with fibrinogen concentrate Haemocomplettan","volume":"1","author":"Siegmund","year":"2003","journal-title":"J Thromb Haemost"},{"key":"R15-8-20210203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.transci.2004.04.003","article-title":"Pharmacokinetic properties of a pasteurised fibrinogen concentrate","volume":"32","author":"Kreuz","year":"2005","journal-title":"Transfus Apher Sci"},{"key":"R16-8-20210203","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1213\/01.ane.0000280481.18570.27","article-title":"Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration","volume":"105","author":"Mittermayr","year":"2007","journal-title":"Anesth Analg"},{"key":"R17-8-20210203","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1182\/blood.V112.11.2268.2268","article-title":"Pharmacokinetic evaluation of a fibrinogen concentrate in patients with congenital fibrinogen deficiency","volume":"112","author":"Manco-Johnson","year":"2008","journal-title":"Blood"},{"key":"R18-8-20210203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1160\/TH07-04-0274","article-title":"Update on antithrombin I (fibrin)","volume":"98","author":"Mosesson","year":"2007","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"R19-8-20210203","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000204039","article-title":"In vivo models of thrombogenic potential: usefulness and limitations","volume":"94","author":"MacGregor","year":"1995","journal-title":"Acta Haematol"},{"key":"R20-8-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0049-3848(00)00397-2","article-title":"Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor","volume":"101","author":"Elg","year":"2001","journal-title":"Thromb Res"},{"key":"R21-8-20210203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1365-2516.2002.00532.x","article-title":"Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events","volume":"8","author":"Ehrlich","year":"2002","journal-title":"Haemophilia"},{"key":"R22-8-20210203","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1538-7836.2004.00944.x","article-title":"Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity","volume":"2","author":"Aledort","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R23-8-20210203","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2125.1998.00713.x","article-title":"Pharmacovigilance in the pharmaceutical industry","volume":"45","author":"Talbot","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"R24-8-20210203","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"R25-8-20210203","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa051379","article-title":"The risk associated with aprotinin in cardiac surgery","volume":"354","author":"Mangano","year":"2006","journal-title":"N Engl J Med"},{"key":"R26-8-20210203","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198408233110804","article-title":"Fibrinogen as a risk factor for stroke and myocardial infarction","volume":"311","author":"Wilhelmsen","year":"1984","journal-title":"N Engl J Med"},{"key":"R27-8-20210203","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1161\/01.STR.0000141701.36371.d1","article-title":"Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke","volume":"35","author":"Rothwell","year":"2004","journal-title":"Stroke"},{"key":"R28-8-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1191\/1358863x03vm494ra","article-title":"Fibrinogen \u2013 marker or mediator of vascular disease?","volume":"8","author":"Reinhart","year":"2003","journal-title":"Vasc Med"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MBC.0b013e32832da1c5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:00:43Z","timestamp":1786039243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200910000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32832da1c5","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}